IP Library Granted Patent US 7,331,460
Granted Patent B2
US 7,331,460 · App. 11/325,364 · Granted Feb 19, 2008

Shielded medicament package

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,331,460
App. No.
11/325,364
Granted
Feb 19, 2008
Kind
B2
Abstract

A shielded medication package including a blister portion and a blister shield attached to a backing substrate. Accessing a medicament is easy for an adult to accomplish, yet the package resists children biting and picking at the blister portion. The blister portion contains a base layer and a blister layer. The blister layer includes an article receiving blister designed for holding the medicament. A blister shield overlays the blister portion. The blister shield includes a blister well that cooperates with the article receiving blister. The blister shield protects the article receiving blister from substantially lateral forces. To eject the medicament, application of a substantially orthogonal force to the article receiving blister is required.

Claims (55)

1. A medicament package ( 10 ) for housing a medicament (M), comprising:

(a) a blister portion ( 100 ) having:

(i) a base layer ( 110 ) having a base layer perimeter ( 120 ), a base layer exterior surface, and a base layer interior surface ( 140 );

(ii) a blister layer ( 150 ) having a blister layer perimeter ( 160 ), a blister layer exterior surface ( 170 ), a blister layer interior surface ( 180 ), and including an article receiving blister ( 190 ), having a blister perimeter ( 196 ) and a blister height ( 198 ), formed therein, wherein the article receiving blister ( 190 ) is designed for holding the medicament (M); wherein

(iii) at least five percent of the surface area of the base layer interior surface ( 140 ) is joined to the blister layer interior surface ( 180 ) thereby sealing the medicament (M) in the article receiving blister ( 190 );

(b) a blister shield ( 300 ) having a blister shield height ( 360 ), a blister shield support bearing edge ( 303 ), a blister shield top surface ( 310 ), and a blister shield bottom surface ( 320 ), wherein the blister shield ( 300 ) is formed with a blister well ( 340 ) having a well interior perimeter ( 342 ) such that the blister well ( 340 ) cooperates with the article receiving blister ( 190 );

(c) a backing substrate ( 400 ) having a backing substrate perimeter ( 401 ), a backing substrate interior surface ( 410 ), and a backing substrate exterior surface ( 420 ), wherein the backing substrate ( 400 ) is formed to have an article dispensing region ( 440 ) having an article dispensing region perimeter ( 442 ), wherein the article dispensing region ( 440 ) is configured to cooperate with the blister portion ( 100 ); and

(d) wherein the blister portion ( 100 ) is located between the blister shield ( 300 ) and the backing substrate ( 400 ) such that the article receiving blister ( 190 ), the blister well ( 340 ), and the article dispensing region ( 440 ) substantially align and the blister well ( 340 ) cooperates with the article receiving blister ( 190 ) to shield, in part, the article receiving blister ( 190 ) from the application of lateral forces thereby requiring application of a substantially orthogonal force to the article receiving blister ( 190 ) to result in the medicament (M) breaking through the base layer ( 110 ), and passing out of the article dispensing region ( 440 ).

2. The medicament package ( 10 ) of claim 1 , wherein the blister shield height ( 360 ) is between 25% of the blister height ( 198 ) and 250% of the blister height ( 198 ).

3. The medicament package ( 10 ) of claim 1 , wherein the blister shield height ( 360 ) is between 75% of the blister height ( 198 ) and 125% of the blister height ( 198 ).

4. The medicament package ( 10 ) of claim 1 , wherein the blister shield height ( 360 ) is substantially equal to the blister height ( 198 ).

5. The medicament package ( 10 ) of claim 1 , further including a dispensing substrate ( 200 ) having a dispensing substrate perimeter ( 201 ), a dispensing substrate interior surface ( 210 ), and a dispensing substrate exterior surface ( 220 ), wherein the dispensing substrate ( 200 ) is formed to have a dispensing substrate blister receiver ( 230 ) configured to cooperate with the blister portion ( 100 ) and the blister shield ( 300 ) such that a portion of the article receiving blister ( 190 ) and a portion of the blister shield ( 300 ) extends through the dispensing substrate ( 200 ) from the dispensing substrate interior surface ( 210 ) to the dispensing substrate exterior surface ( 220 ), and the blister shield ( 300 ) has a blister shield flange ( 315 ) positioned between the dispensing substrate ( 200 ) and the backing substrate ( 400 ).

6. The medicament package ( 10 ) of claim 1 , further including a retaining substrate ( 500 ) having a retaining substrate interior surface ( 510 ), a retaining substrate exterior surface ( 520 ), and a retaining substrate blister receiver ( 530 ) wherein the retaining substrate interior surface ( 510 ) is adjacent to the blister layer exterior surface ( 170 ) and a portion of the article receiving blister ( 190 ) extends through the retaining substrate blister receiver ( 530 ) from the retaining substrate interior surface ( 510 ) to the retaining substrate exterior surface ( 520 ), and wherein the blister shield support bearing edge ( 303 ) is adjacent to the retaining substrate exterior surface ( 520 ) such that the retaining substrate ( 500 ) retains and positions the blister portion ( 100 ) to ensure the article receiving blister ( 190 ), the blister well ( 340 ), and the article dispensing region ( 440 ) substantially align.

7. The medicament package ( 10 ) of claim 5 , further including a retaining substrate ( 500 ) having a retaining substrate interior surface ( 510 ), a retaining substrate exterior surface ( 520 ), and a retaining substrate blister receiver ( 530 ) wherein the retaining substrate interior surface ( 510 ) is adjacent to the blister layer exterior surface ( 170 ) and a portion of the article receiving blister ( 190 ) extends through the retaining substrate blister receiver ( 530 ) from the retaining substrate interior surface ( 510 ) to the retaining substrate exterior surface ( 520 ) such that the retaining substrate ( 500 ) retains and positions the blister portion ( 100 ) to ensure the article receiving blister ( 190 ), the blister well ( 340 ), and the article dispensing region ( 440 ) substantially align.

8. The medicament package ( 10 ) of claim 7 , wherein the dispensing substrate ( 200 ), the backing substrate ( 400 ), and the retaining substrate ( 500 ) are formed of a single substrate folded about a backing substrate dispensing fold line ( 450 ) and a backing substrate retainage fold line ( 460 ).

9. The medicament package ( 10 ) of claim 1 , wherein the backing substrate article dispensing region ( 440 ) defines a void formed in the backing substrate ( 400 ) sized to cooperate with the medicament (M) so that the medicament (M) may pass through the article dispensing region ( 440 ) for distribution.

10. The medicament package ( 10 ) of claim 1 , wherein the backing substrate article dispensing region ( 440 ) is an integral portion of the backing substrate ( 400 ) having a separation line ( 444 ) selectively reducing the strength of the backing substrate ( 400 ), thereby permitting the medicament (M) to break a portion of the article dispensing region ( 440 ) free of the backing substrate ( 400 ) along the separation line ( 444 ) when the medicament (M) is exposed to an orthogonal force, thereby permitting the medicament (M) to pass through the article dispensing region ( 440 ) for distribution.

11. The medicament package ( 10 ) of claim 10 , wherein the separation line ( 444 ) is located substantially on the article dispensing region perimeter ( 442 ).

12. The medicament package ( 10 ) of claim 11 , wherein the separation line ( 444 ) comprises one or more of the group consisting of die cuts, perforations, indentations, score lines, and weakened fracture lines.

13. The medicament package ( 10 ) of claim 1 , wherein the blister shield ( 300 ) is comprised of a material and thickness that cannot be readily deformed by a human finger pushing adjacent to the article receiving blister ( 190 ) thereby preventing exposure of the article receiving blister ( 190 ) to the application of substantially lateral forces and thus limiting access to the medicament (M) via compromise of the article receiving blister ( 190 ).

14. The medicament package ( 10 ) of claim 1 , further including a well sidewall ( 344 ) and a well free edge ( 343 ) such that application of orthogonal force to the blister shield ( 300 ) adjacent to the article receiving blister ( 190 ) causes the well free edge ( 343 ) to contact the blister layer exterior surface ( 170 ) and whereby the well sidewall ( 344 ) reduces exposure of the article receiving blister ( 190 ) to the application of lateral forces and thus limits access to the medicament (M) via compromise of the article receiving blister ( 190 ).

15. The medicament package ( 10 ) of claim 1 , wherein the blister well ( 340 ) is sized to cooperate with the dimensions of a tip of a human finger.

16. A medicament package ( 10 ) for housing a medicament (M), comprising:

(a) a blister portion ( 100 ) having:

(i) a base layer ( 110 ) having a base layer perimeter ( 120 ), a base layer exterior surface, and a base layer interior surface ( 140 );

(ii) a blister layer ( 150 ) having a blister layer perimeter ( 160 ), a blister layer exterior surface ( 170 ), a blister layer interior surface ( 180 ), and including an article receiving blister ( 190 ), having a blister perimeter ( 196 ) and a blister height ( 198 ), formed therein, wherein the article receiving blister ( 190 ) is designed for holding the medicament (M); wherein

(iii) at least five percent of the surface area of the base layer interior surface ( 140 ) is joined to the blister layer interior surface ( 180 ) thereby sealing the medicament (M) in the article receiving blister ( 190 );

(b) a blister shield ( 300 ) having a blister shield support bearing edge ( 303 ), a blister shield top surface ( 310 ), a blister shield bottom surface ( 320 ), a blister well ( 340 ), and a blister shield height ( 360 ); wherein

(i) the blister well ( 340 ) is sized to cooperate with the dimensions of a tip of a human finger;

(ii) the blister shield height ( 360 ) is between 75% of the blister height ( 198 ) and 125% of the blister height ( 198 );

(c) a backing substrate ( 400 ) having a backing substrate perimeter ( 401 ), a backing substrate interior surface ( 410 ), and a backing substrate exterior surface ( 420 ), wherein the backing substrate ( 400 ) is formed to have an article dispensing region ( 440 ) having an article dispensing region perimeter ( 442 ), wherein the article dispensing region ( 440 ) is configured to cooperate with the blister portion ( 100 ); and

(d) wherein the blister portion ( 100 ) is located between the blister shield ( 300 ) and the backing substrate ( 400 ) such that the article receiving blister ( 190 ), the blister well ( 340 ), and the article dispensing region ( 440 ) align and the blister well ( 340 ) cooperates with the article receiving blister ( 190 ) to shield the article receiving blister ( 190 ) from the application of lateral forces thereby limiting access to the medicament (M) via compromise of the article receiving blister ( 190 ) and requiring application of a orthogonal force to the article receiving blister ( 190 ) to result in the medicament (M) breaking through the base layer ( 110 ), and passing out of the article dispensing region ( 440 ).

17. The medicament package ( 10 ) of claim 16 , wherein the blister shield height ( 360 ) is substantially equal to the blister height ( 198 ).

18. The medicament package ( 10 ) of claim 16 , further including a dispensing substrate ( 200 ) having a dispensing substrate perimeter ( 201 ), a dispensing substrate interior surface ( 210 ), and a dispensing substrate exterior surface ( 220 ), wherein the dispensing substrate ( 200 ) is formed to have a dispensing substrate blister receiver ( 230 ) configured to cooperate with the blister portion ( 100 ) and the blister shield ( 300 ) such that a portion of the article receiving blister ( 190 ) and a portion of the blister shield ( 300 ) extends through the dispensing substrate ( 200 ) from the dispensing substrate interior surface ( 210 ) to the dispensing substrate exterior surface ( 220 ), and the blister shield ( 300 ) has a blister shield flange ( 315 ) positioned between the dispensing substrate ( 200 ) and the backing substrate ( 400 ).

19. The medicament package ( 10 ) of claim 16 , further including a retaining substrate ( 500 ) having a retaining substrate interior surface ( 510 ), a retaining substrate exterior surface ( 520 ), and a retaining substrate blister receiver ( 530 ) wherein the retaining substrate interior surface ( 510 ) is adjacent to the blister layer exterior surface ( 170 ) and a portion of the article receiving blister ( 190 ) extends through the retaining substrate blister receiver ( 530 ) from the retaining substrate interior surface ( 510 ) to the retaining substrate exterior surface ( 520 ), and wherein the blister shield support bearing edge ( 303 ) is adjacent to the retaining substrate exterior surface ( 520 ) such that the retaining substrate ( 500 ) retains and positions the blister portion ( 100 ) to ensure the article receiving blister ( 190 ), the blister well ( 340 ), and the article dispensing region ( 440 ) align.

20. The medicament package ( 10 ) of claim 18 , further including a retaining substrate ( 500 ) having a retaining substrate interior surface ( 510 ), a retaining substrate exterior surface ( 520 ), and a retaining substrate blister receiver ( 530 ) wherein the retaining substrate interior surface ( 510 ) is adjacent to the blister layer exterior surface ( 170 ) and a portion of the article receiving blister ( 190 ) extends through the retaining substrate blister receiver ( 530 ) from the retaining substrate interior surface ( 510 ) to the retaining substrate exterior surface ( 520 ) such that the retaining substrate ( 500 ) retains and positions the blister portion ( 100 ) to ensure the article receiving blister ( 190 ), the blister well ( 340 ), and the article dispensing region ( 440 ) substantially align.

21. The medicament package ( 10 ) of claim 20 , wherein the dispensing substrate ( 200 ), the backing substrate ( 400 ), and the retaining substrate ( 500 ) are formed of a single substrate folded about a backing substrate dispensing fold line ( 450 ) and a backing substrate retainage fold line ( 460 ).

22. The medicament package ( 10 ) of claim 16 , wherein the backing substrate article dispensing region ( 440 ) defines a void formed in the backing substrate ( 400 ) sized to cooperate with the medicament (M) so that the medicament (M) may pass through the article dispensing region ( 440 ) for distribution.

23. The medicament package ( 10 ) of claim 16 , wherein the backing substrate article dispensing region ( 440 ) is an integral portion of the backing substrate ( 400 ) having a separation line ( 444 ) selectively reducing the strength of the backing substrate ( 400 ), thereby permitting the medicament (M) to break a portion of the article dispensing region ( 440 ) free of the backing substrate ( 400 ) along the separation line ( 444 ) when the medicament (M) is exposed to an orthogonal force, thereby permitting the medicament (M) to pass through the article dispensing region ( 440 ) for distribution.

24. The medicament package ( 10 ) of claim 23 , wherein the separation line ( 444 ) is located substantially on the article dispensing region perimeter ( 442 ).

25. The medicament package ( 10 ) of claim 24 , wherein the separation line ( 444 ) comprises one or more of the group consisting of die cuts, perforations, indentations, score lines, and weakened fracture lines.

26. The medicament package ( 10 ) of claim 16 , further including a well sidewall ( 344 ) and a well free edge ( 343 ) such that application of orthogonal force to the blister shield ( 300 ) adjacent to the article receiving blister ( 190 ) causes the well free edge ( 343 ) to contact the blister layer exterior surface ( 170 ) and whereby the well sidewall ( 344 ) reduces exposure of the article receiving blister ( 190 ) to the application of lateral forces and thus prevents access to the medicament (M) via compromise of the article receiving blister ( 190 ).

27. The child medicament package ( 10 ) of claim 16 , wherein the blister well ( 340 ) is sized to cooperate with the dimensions of a tip of a human finger.

28. A medicament package ( 10 ) for housing a medicament (M), comprising:

(a) a blister portion ( 100 ) having:

(i) a base layer ( 110 ) having a base layer perimeter ( 120 ), a base layer exterior surface, and a base layer interior surface ( 140 );

(ii) a blister layer ( 150 ) having a blister layer perimeter ( 160 ), a blister layer exterior surface ( 170 ), a blister layer interior surface ( 180 ), and including an article receiving blister ( 190 ), having a blister perimeter ( 196 ) and a blister height ( 198 ), formed therein, wherein the article receiving blister ( 190 ) is designed for holding the medicament (M); wherein

(iii) at least five percent of the surface area of the base layer interior surface ( 140 ) is joined to the blister layer interior surface ( 180 ) thereby sealing the medicament (M) in the article receiving blister ( 190 );

(b) a dispensing substrate ( 200 ) having a dispensing substrate perimeter ( 201 ), a dispensing substrate interior surface ( 210 ), a dispensing substrate exterior surface ( 220 ), and the dispensing substrate ( 200 ) is formed to have a dispensing substrate blister receiver ( 230 );

(c) a blister shield ( 300 ) having a blister shield support bearing edge ( 303 ), a blister shield top surface ( 310 ), a blister shield bottom surface ( 320 ), a blister well ( 340 ), and a blister shield height ( 360 ); wherein

(i) the blister well ( 340 ) is formed with a well interior perimeter ( 342 ) such that the blister well ( 340 ) cooperates with the article receiving blister ( 190 ); and wherein

(ii) the blister shield height ( 360 ) is substantially equal to the blister height ( 198 );

(d) a backing substrate ( 400 ) having a backing substrate perimeter ( 401 ), a backing substrate interior surface ( 410 ), and a backing substrate exterior surface ( 420 ), wherein the backing substrate ( 400 ) is formed to have an article dispensing region ( 440 ) having an article dispensing region perimeter ( 442 ), wherein the article dispensing region ( 440 ) is configured to cooperate with the blister portion ( 100 );

(e) a retaining substrate ( 500 ) having a retaining substrate interior surface ( 510 ), a retaining substrate exterior surface ( 520 ), and a retaining substrate blister receiver ( 530 ) that is designed to cooperate with the blister portion ( 100 ); and

(f) wherein the blister portion ( 100 ) lies between the backing substrate ( 400 ) and the retaining substrate ( 500 ) with the blister shield ( 300 ) held in place by the dispensing substrate ( 200 ), and wherein the article receiving blister ( 190 ), the blister well ( 340 ), and the article dispensing region ( 440 ) align and the blister well ( 340 ) cooperates with the article receiving blister ( 190 ) to shield, in part, the article receiving blister ( 190 ) from the application of lateral forces thereby preventing access to the medicament (M) via compromise of the article receiving blister ( 190 ) and requiring application of a orthogonal force to the article receiving blister ( 190 ) to result in the medicament (M) breaking through the base layer ( 110 ), and passing out of the article dispensing region ( 440 ).

Assignments (23)
RELEASE OF FIRST LIEN PATENT SECURITY AGREEMENT R/F 054583/0911 Recorded Feb 5, 2025
From: JEFFERIES FINANCE LLC
To: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
Reel/Frame 070125/0445 →
SECURITY INTEREST Recorded Jan 22, 2025
From: PACKAGING COORDINATORS, LLC
To: BLUE OWL CAPITAL CORPORATION
Reel/Frame 069969/0363 →
RELEASE OF SECURITY INTEREST IN PATENTS – SECOND LIEN (REEL/FRAME 054583/0980) Recorded Feb 22, 2024
From: BLUE OWL CAPITAL CORPORATION (F/K/A/ OWL ROCK CAPITAL CORPORATION), AS COLLATERAL AGENT
To: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
Reel/Frame 066645/0317 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (FIRST LIEN) Recorded Dec 3, 2020
From: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 054583/0911 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Dec 3, 2020
From: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
To: OWL ROCK CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 054583/0980 →
RELEASE OF FIRST LIEN SECURITY INTEREST Recorded Dec 1, 2020
From: JEFFERIES FINANCE LLC
To: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
Reel/Frame 054554/0952 →
RELEASE OF SECOND LIEN SECURITY INTEREST Recorded Dec 1, 2020
From: JEFFERIES FINANCE LLC
To: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
Reel/Frame 054554/0964 →
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2016
From: ROYAL BANK OF CANADA
To: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
Reel/Frame 039064/0900 →
SECURITY INTEREST Recorded Jul 1, 2016
From: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 039063/0563 →
SECURITY INTEREST Recorded Jul 1, 2016
From: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 039063/0649 →
RELEASE OF SECURITY INTEREST Recorded Jul 1, 2016
From: ROYAL BANK OF CANADA
To: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
Reel/Frame 039065/0015 →
SECURITY INTEREST Recorded Nov 4, 2015
From: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
To: ROYAL BANK OF CANADA, AS AGENT
Reel/Frame 036954/0592 →
SECURITY INTEREST Recorded Nov 3, 2015
From: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
To: ROYAL BANK OF CANADA, AS AGENT
Reel/Frame 036951/0706 →
RELEASE OF SECURITY INTEREST Recorded Aug 1, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
Reel/Frame 033460/0176 →
RELEASE OF SECURITY INTEREST Recorded May 13, 2013
From: COMERICA BANK
To: PACKAGING COORDINATORS, INC.; CP USA, LLC
Reel/Frame 030399/0888 →
SECURITY AGREEMENT Recorded May 10, 2013
From: PACKAGING COORDINATORS, LLC; ANDERSONBRECON INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 030391/0241 →
CHANGE OF NAME BY CERTIFICATE OF AMENDMENT Recorded Jan 15, 2013
From: CP USA, LLC
To: PACKAGING COORDINATORS, LLC
Reel/Frame 029634/0996 →
SECURITY AGREEMENT Recorded Jul 2, 2012
From: PACKAGING COORDINATORS, INC.; PACKAGING COORDINATORS, LLC, FORMERLY KNOWN AS CP USA, LLC
To: COMERICA BANK
Reel/Frame 028489/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2012
From: R.P. SCHERER TECHNOLOGIES, LLC
To: CP USA, LLC
Reel/Frame 028404/0528 →
CHANGE OF NAME Recorded Feb 28, 2012
From: R.P. SCHERER TECHNOLOGIES, INC.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 027776/0314 →
CHANGE OF NAME Recorded Jul 24, 2007
From: CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 409, INC.; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC
To: CATALENT USA WOODSTOCK, INC.; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT USA PAINTBALL, INC.; CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 019588/0622 →
SECURITY AGREEMENT Recorded May 22, 2007
From: PTS ACQUISITION CORP.; PTS INTERMEDIATE HOLDINGS LLC; CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; GLACIER CORPORATION; CARDINAL HEALTH 409, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 019323/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2006
From: BARNDT, DAVID R.; CHADWICK, DENNIS; GERDAN, VICTOR JR.
To: R.P. SCHERER TECHNOLOGIES, INC.
Reel/Frame 017438/0989 →